Valence-Logo
Beliebt
Anmelden

Zur Watchlist hinzufügen
Profi-Chart

Mesabi Trust

NYSE: MSB · Echtzeitkurs · USD
22.96
-0.32 (-1.37%)
Zum Schluss: Aug 14, 2026, 3:56 PM
22.96
+0.00%
Nachbörslich: 5:05 PM

Mesabi Trust (MSB) Stock Price, Analysis & Data

-1.37%
Geld22.25
Marktkapitalisierung301.24 Mio
Umsatz (TTM)15.04 Mio
Nettogewinn (TTM)11.33 Mio
Beta0.33
EPS (ttm)0.86
KGV (TTM)26.7
Forward-KGV-1.16
KBV (TTM)16.42
KUV (TTM)20.04
Earnings Daten/a
Brief23.11
Volumen35,937
Ø Vol. (20D)47,182
Eröffnung23.19
Vortagesschluss23.28
Tagesspanne22.77 - 23.59
52-Wk Range21.60 - 42.38
Analystn/a
Kurszieln/a
Dividenden$0.89 (3.82%)
Ex-Dividenden-Datum30. Juli 2026

Über MSB

Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. Mesabi Trust was incorporated in 1961 and is based in New York, New York....

[Mehr lesen]
Branche Steel
Sektor Basic Materials
IPO Datum Feb 21, 1973
Mitarbeiter n/a
Börse NYSE
Tickersymbol MSB
Website https://mesabi-trust.com
Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2026 betrug der Umsatz von Mesabi Trust 16.57 Mio, ein Rückgang von -34.91% im Vergleich zum Vorjahr (25.46 Mio). Der Gewinn lag bei 13.87 Mio, ein Rückgang von -85.13 %.

Finanzberichte

Gewinnüberraschung

Mesabi Trust hat die Quartalszahlen am Apr 10, 2013 veröffentlicht:
  • Umsatz von $2.08 Mio verfehlt die Erwartungen um $0, mit -52.23% Rückgang im Jahresvergleich.
  • EPS von 0.36 verfehlt die Erwartungen um -0.06, mit -25.00% Rückgang im Jahresvergleich.
    news image

    vor 4 Monaten · Simply Wall St.

    Assessing Cleveland-Cliffs (CLF) Valuation After Mesabi Trust Distribution Cut Highlights Operational Uncertainty

    Mesabi Trust’s decision to cut its distribution, after receiving lower royalty payments from Cleveland-Cliffs (CLF), has drawn fresh attention to uncertainties around the miner’s Northshore iron ore o...

    news image

    vor 4 Monaten · Simply Wall St.

    ASX April 2026 Stocks Estimated To Be Trading Below Fair Value

    The Australian stock market is experiencing a period of optimism, with the ASX 200 futures seeing a significant rise as global equities receive a boost from renewed geopolitical negotiations. Amidst t...

    news image

    vor 4 Monaten · Simply Wall St.

    Gregory George Adds To Mesoblast Position With Multi-Market Share Purchases

    Mesoblast Limited ( ASX:MSB ) shareholders (or potential shareholders) will be happy to see that insider Gregory George...

    news image

    vor 4 Monaten · Simply Wall St.

    Mesoblast (ASX:MSB) Is Down 11.0% After FDA Clears Registrational DMD Trial For Ryoncil - Has The Bull Case Changed?

    Mesoblast recently announced that the US FDA has granted Investigational New Drug clearance to move directly into a registrational clinical trial of Ryoncil in children with Duchenne muscular dystroph...

    news image

    vor 4 Monaten · Simply Wall St.

    Is Mesoblast (ASX:MSB) Price Swings Creating A Possible Valuation Opportunity?

    If you are wondering whether Mesoblast at around A$2.02 is still priced attractively or already reflecting high expectations, the valuation story matters more than ever. The share price has seen mixed...

    Seite 1 von 2